These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 9781927

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Losartan-sensitive renal damage caused by chronic NOS inhibition does not involve increased renal angiotensin II concentrations.
    Verhagen AM, Braam B, Boer P, Gröne HJ, Koomans HA, Joles JA.
    Kidney Int; 1999 Jul; 56(1):222-31. PubMed ID: 10411696
    [Abstract] [Full Text] [Related]

  • 3. Endothelin and angiotensin mediate most glomerular responses to nitric oxide inhibition.
    Qiu C, Baylis C.
    Kidney Int; 1999 Jun; 55(6):2390-6. PubMed ID: 10354287
    [Abstract] [Full Text] [Related]

  • 4. Facilitation of renal autoregulation by angiotensin II is mediated through modulation of nitric oxide.
    Guan Z, Willgoss DA, Matthias A, Manley SW, Crozier S, Gobe G, Endre ZH.
    Acta Physiol Scand; 2003 Oct; 179(2):189-201. PubMed ID: 14510783
    [Abstract] [Full Text] [Related]

  • 5. Relative roles of nitric oxide, prostanoids and angiotensin II in the regulation of canine glomerular hemodynamics. A micropuncture study.
    Kramer HJ, Horacek V, Bäcker A, Vaneckova I, Heller J.
    Kidney Blood Press Res; 2004 Oct; 27(1):10-7. PubMed ID: 14583658
    [Abstract] [Full Text] [Related]

  • 6. Contribution of angiotensin II to renal hemodynamic and excretory responses to nitric oxide synthesis inhibition in the rat.
    Takenaka T, Mitchell KD, Navar LG.
    J Am Soc Nephrol; 1993 Oct; 4(4):1046-53. PubMed ID: 8286713
    [Abstract] [Full Text] [Related]

  • 7. The role of basally synthesized nitric oxide in modulating the renal vasoconstrictor action of angiotensin II.
    Aki Y, Tomohiro A, Nishiyama A, Kiyomoto K, Kimura S, Abe Y.
    Hypertens Res; 1997 Dec; 20(4):251-6. PubMed ID: 9453259
    [Abstract] [Full Text] [Related]

  • 8. AT2-antagonist sensitive potentiation of angiotensin II-induced vasoconstrictions by blockade of nitric oxide synthesis in rat renal vasculature.
    Muller C, Endlich K, Barthelmebs M, Helwig JJ.
    Br J Pharmacol; 1997 Dec; 122(7):1495-501. PubMed ID: 9421301
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Oxygen consumption in the kidney: effects of nitric oxide synthase isoforms and angiotensin II.
    Deng A, Miracle CM, Suarez JM, Lortie M, Satriano J, Thomson SC, Munger KA, Blantz RC.
    Kidney Int; 2005 Aug; 68(2):723-30. PubMed ID: 16014049
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Role of AT1 receptors in the renal papillary effects of acute and chronic nitric oxide inhibition.
    Ortíz MC, Fortepiani LA, Ruiz-Marcos FM, Atucha NM, García-Estañ J.
    Am J Physiol; 1998 Mar; 274(3):R760-6. PubMed ID: 9580145
    [Abstract] [Full Text] [Related]

  • 13. Renal responses to AT1 blockade in angiotensin II-induced hypertensive rats.
    Wang CT, Zou LX, Navar LG.
    J Am Soc Nephrol; 1997 Apr; 8(4):535-42. PubMed ID: 10495782
    [Abstract] [Full Text] [Related]

  • 14. Angiotensin II blockade does not prevent renal effects of L-NAME in sodium-repleted humans.
    Montanari A, Tateo E, Fasoli E, Giberti D, Perinotto P, Novarini A, Dall'Aglio P.
    Hypertension; 1997 Sep; 30(3 Pt 2):557-62. PubMed ID: 9322981
    [Abstract] [Full Text] [Related]

  • 15. Angiotensin II-induced renal responses in anesthetized rabbits: effects of N omega-nitro-L-arginine methyl ester and losartan.
    Adachi Y, Hashimoto K, Hisa H, Yoshida M, Suzuki-Kusaba M, Satoh S.
    Eur J Pharmacol; 1996 Jul 18; 308(2):165-71. PubMed ID: 8840128
    [Abstract] [Full Text] [Related]

  • 16. The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats.
    Siragy HM, Carey RM.
    J Clin Invest; 1997 Jul 15; 100(2):264-9. PubMed ID: 9218502
    [Abstract] [Full Text] [Related]

  • 17. [7-D-ALA]-angiotensin 1-7 blocks renal actions of angiotensin 1-7 in the anesthetized rat.
    Vallon V, Heyne N, Richter K, Khosla MC, Fechter K.
    J Cardiovasc Pharmacol; 1998 Jul 15; 32(1):164-7. PubMed ID: 9676737
    [Abstract] [Full Text] [Related]

  • 18. Renal effects of acute endothelial-derived relaxing factor blockade are not mediated by angiotensin II.
    Baylis C, Engels K, Samsell L, Harton P.
    Am J Physiol; 1993 Jan 15; 264(1 Pt 2):F74-8. PubMed ID: 8430832
    [Abstract] [Full Text] [Related]

  • 19. Potentiation of L-NAME-induced systemic and renal vasoconstrictor responses by alpha1-adrenoceptor antagonism.
    van der Linde NA, Boomsma F, van den Meiracker AH.
    J Hypertens; 2005 May 15; 23(5):1017-24. PubMed ID: 15834288
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.